Skip to content

Pethidine efficacy in prevention of shivering during cesarean section

The clinical trial study of comparison intravenous pethidine and sterile water efficacy in prevention of shivering during cesarean section under spinal anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016040527242N1
Enrollment
80
Registered
2016-08-19
Start date
2016-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of intravenous pethidine on preventing post spinal anestesia shivering in cesarean section. O89.4

Interventions

Intervention 1: Patient in Group P received 20mg (2cc) pethidine intravenously before spinal anesthesia. Intervention 2: Patient in Group C received 2cc strile water intravenously before spinal anesth
Prevention
Patient in Group P received 20mg (2cc) pethidine intravenously before spinal anesthesia.
Patient in Group C received 2cc strile water intravenously before spinal anesthesia.

Sponsors

Sabzevar University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:ISI I pregnant women 15-40 years old with normal pregnancy that candidate for cesarean section under spinal anesthesia Exclusion criteria:history of pethidine allergy; contraindication for pethidine injection; history of opioid addiction or opioid abuse; patient with sever shivering has been given drug

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Shivering. Timepoint: Before spinal anesthesia; 5 min after spinal anesthesia; every 10 min in operating room and recovery. Method of measurement: Grade 0 (no shivering) to grade 4 (involved whole body muscles).

Secondary

MeasureTime frame
Nausea. Timepoint: After pethidine injection. Method of measurement: visual.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSolmaz Dastras

Sabzevar University of Medical Sciences

solmasdastras@yahoo.com+98 51 4423 8102

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026